ECONOMIC EVALUATION OF SUNITINIB AS FIRST-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA IN COLOMBIA

被引：0
|
作者：
Prieto, V. A. [1 ]
Reyes, J. M. [1 ]
Lopez-Cabra, C. [2 ]
Diaz, J. A. [3 ]
Urrego-Novoa, J. R. [4 ]
机构：
[1] Pfizer SAS, Bogota, Colombia
[2] Univ Rosario, Bogota, Colombia
[3] Univ Nacl Colombia, Bogota, Colombia
[4] Univ Nacl Colombia, Bogota, Colombia
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1586
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN87
引用
收藏
页码：A149 / A149
页数：1
相关论文
共 50 条
  • [1] Economic evaluation of sunitinib malate for the first-line treatment of metastatic renal cell carcinoma
    Remak, Edit
    Charbonneau, Claudie
    Negrier, Sylvie
    Kim, Sindy T.
    Motzer, Robert J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) : 3995 - 4000
  • [2] Economic evaluation of sunitinib as first-line treatment for metastatic renal cell carcinoma in Mexico
    Emilio, Mucino-Ortega
    Joaquin Federico, Mould-Quevedo
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2010, 9 (02): : 48 - 57
  • [3] ECONOMIC EVALUATION OF SUNITINIB FOR THE FIRST-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN RUSSIAN FEDERATION
    Yagudina, R.
    Kulikov, A.
    Novikov, I
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A222 - A222
  • [4] Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastatic Renal Cell Carcinoma Comment
    Penson, David F.
    [J]. JOURNAL OF UROLOGY, 2009, 181 (03): : 1067 - 1067
  • [5] PHARMACOECONOMIC EVALUATION OF SUNITINIB MALATE FOR FIRST-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN MEXICO
    Tenorio, C.
    Vargas, J.
    Rizo-Rios, P.
    Flores-Gil, O.
    Martinez-Fonseca, J.
    Mould-Quevedo, J.
    Davila-Loaiza, G.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A44 - A45
  • [6] Economic Evaluation of Everolimus versus Sorafenib for the Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line Sunitinib
    Casciano, Roman
    Chulikavit, Maruit
    Di Lorenzo, Giuseppe
    Liu, Zhimei
    Baladi, Jean-Francois
    Wang, Xufang
    Robertson, Justin
    Garrison, Lou
    [J]. VALUE IN HEALTH, 2011, 14 (06) : 846 - 851
  • [7] Sunitinib First-line Treatment in Metastatic Renal Cell Carcinoma: Costs and Effects
    Vuorinen, Riikka-Liisa
    Paunu, Niina
    Turpeenniemi-Hujanen, Taina
    Reunamo, Taina
    Jekunen, Antti
    Kataja, Vesa
    Sintonen, Harri
    Purmonen, Timo
    Kellokumpu-Lehtinen, Pirkko-Liisa
    [J]. ANTICANCER RESEARCH, 2019, 39 (10) : 5559 - 5564
  • [8] Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
    Vazquez, Sergio
    Leon, Luis
    Fernandez, Ovidio
    Lazaro, Martin
    Grande, Enrique
    Aparicio, Luis
    [J]. ADVANCES IN THERAPY, 2012, 29 (03) : 202 - 217
  • [9] Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
    Sergio Vázquez
    Luis León
    Ovidio Fernández
    Martín Lázaro
    Enrique Grande
    Luis Aparicio
    [J]. Advances in Therapy, 2012, 29 : 202 - 217
  • [10] Economic evaluation of pazopanib as first-line treatment of metastatic renal cell carcinoma in Greece
    Solakidi, A.
    Kourlaba, G.
    Kontovinis, L.
    Bournakis, E.
    Boutis, A.
    Koutsoukos, K.
    Syrios, J.
    Tzovaras, A.
    Chatzikou, M.
    Michailidi, C.
    Maniadakis, N.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
12345